AICAR inhibits ceramide biosynthesis in skeletal muscle
<p>Abstract</p> <p>Background</p> <p>The worldwide prevalence of obesity has lead to increased efforts to find therapies to treat obesity-related pathologies. Ceramide is a well-established mediator of several health problems that arise from adipose tissue expansion. Th...
Main Authors: | Erickson Katherine A, Smith Melissa E, Anthonymuthu Tamil S, Evanson Michael J, Brassfield Eric S, Hodson Aimee E, Bressler M, Tucker Braden J, Thatcher Mikayla O, Prince John T, Hancock Chad R, Bikman Benjamin T |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-11-01
|
Series: | Diabetology & Metabolic Syndrome |
Subjects: | |
Online Access: | http://www.dmsjournal.com/content/4/1/45 |
Similar Items
-
AICAr, a Widely Used AMPK Activator with Important AMPK-Independent Effects: A Systematic Review
by: Dora Višnjić, et al.
Published: (2021-05-01) -
Lack of Effects of Metformin and AICAR Chronic Infusion on the Development of Hypertension in Dahl Salt-Sensitive Rats
by: Tengis S. Pavlov, et al.
Published: (2017-04-01) -
AICAR and nicotinamide treatment synergistically augment the proliferation and attenuate senescence-associated changes in mesenchymal stromal cells
by: Mohammadhossein Khorraminejad-Shirazi, et al.
Published: (2020-02-01) -
5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranosyl 5'-Monophosphate (AICAR), a Highly Conserved Purine Intermediate with Multiple Effects
by: Bertrand Daignan-Fornier, et al.
Published: (2012-03-01) -
A Facile Synthesis of 5'-Fluoro-5'-deoxyacadesine (5'-F-AICAR): A Novel Non-phosphorylable AICAR Analogue
by: Luciano Mayol, et al.
Published: (2012-11-01)